EMA: Guideline on the clinical investigation of medicinal products for the treatment of urinary incontinence

This guideline considers pharmacodynamic and clinical data required to support indications, dose regimens and durations of therapy for the treatment of urinary incontinence (UI). It applies to the initial development programmes for new agents for the treatment of incontinence and to data generated to support additions and changes to the clinical elements of the marketing authorisation.

kapitał ludzki

fundusz społeczny

Narodowe Centrum Badań i Rozwoju

innowacyjna gospodarka

rozwój regionalny